Merck, the New Jersey-based pharmaceutical giant, will pay Cidara stockholders $221.50 a share in the all-cash deal. Cidara ...
The deal, one of two multibillion-dollar buyouts from Merck this year, centers around a drug that could become an alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback